Hthy is developed by Seroyal USA.

What development phase is Hthy in?

Hthy is FDA-approved (marketed).

What is the generic name of Hthy?

THYROID is the generic (nonproprietary) name of Hthy.

Last reviewed 2026-04-20 · How we verify

Hthy (THYROID)

Seroyal USA · FDA-approved active Quality 6/100

At a glance

Generic name	THYROID
Sponsor	Seroyal USA
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Better Understanding of Fatigue After STroke (NA)
A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD) (PHASE2)
Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer (PHASE2)
Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer (PHASE2)
MHB018A Treatment in Patients With Chronic Thyroid Eye Disease (PHASE3)
Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma (NA)
Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease (PHASE3)
Testing Trametinib and Dabrafenib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol H) (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Hthy CI brief — competitive landscape report
Hthy updates RSS · CI watch RSS
Seroyal USA portfolio CI